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Context: Inadvertent postoperative hypothermia is known to be associated with various 
adverse physiologic effects and is a problem with high incidence. 
 
Objective(s): The aim of this study was to estimate the incidence, predictors and 
outcome of core hypothermia on admission at post-anesthesia care unit. 
 
Design: Observational, prospective study. 
 
Setting: Post-anesthesia care unit of a tertiary hospital: Centro Hospitalar São João, 
Porto, Portugal. During the period of 9 to 27 May 2011. 
 
Patients: 357 patients were admitted and 340 eligible for this study. A written informed 
consent was obtained before surgery. Exclusion criteria were defined as: age under 18 
years; inability to provide informed consent; patient refusal; foreign nationals; 
urgent/emergent/cardiac surgery; neurosurgery or others procedures need to undertake 
therapeutic hypothermia and known neuromuscular disease.  
 
Main outcome measures: Mini-mental state examination, vital signs, perioperative 
variables. 
 
Results: Incidence of hypothermia on admission was 32.4%. Hypothermia was neither a 
risk factor for hospital mortality nor a predictor for longer hospital stay but was for 
longer length of post-anesthesia care unit stay. In univariate analysis: age ≥65 (42% 
versus 30%, p=0.025), body mass index (25.9  5.0 versus 27.8  5.9, p=0.001), high 
risk surgery (35% versus 24%, p=0.040), revised cardiac risk index ˃2  (8% versus 3%, 
p=0.019), general anesthesia (72% versus 13% for locorregional, p=0.016), forced-air 
warming technic (42% versus 28%, p=0.013), intravenous crystalloids administrated 
(median of 1.724 versus 1.236 liters, p<0.001), fasting times (14.0 ± 3.8 versus 15.0 ± 
4.0 hours, p=0.025), duration of anesthesia (median of 150 min. versus 102 min., 
p<0.001) and of surgery (median of 110 versus 70 min., p<0.001) and visual analogue 
scale of pain >3 (median of 2.5 versus 1.0, p= 0.031), were considered predictors of 
hypothermia. In multiple logistic regression analysis, low body mass index, higher 
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scores in revised cardiac risk index, longer duration of anesthesia and higher scores in 
visual analogue scale of pain were considered independent predictors of hypothermia. 
Conclusions: Although the adverse effects of inadvertent hypothermia are well known, 
incidence remains high. Awareness of this fact is critical to its prevention.  
 
Key words: core temperature; inadvertent postoperative hypothermia; incidence; 
predictors; outcome; post-anesthesia care unit. 
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Introduction 
Hypothermia is defined as core body temperature less than 36.0ºC, although some 
studies has considered lower limits because of a high incidence of patients bellow 36 ºC 
and for statistical analyses.
1,2,3
  Inadvertent postoperative hypothermia (IPH) emerges as 
the most common thermic alteration associated with anesthesia and surgery.
4
 Despite of 
core temperature (Tc) normally be tightly controlled in human beings,
5,6 
general 
anesthesia significantly impairs the thermoregulatory system; and the same happens 
with neuraxial (spinal and epidural) anesthesia, even with a potential lesser extent. The 
result is that un-warmed surgical patients almost inevitably become hypothermic.
7 
IPH 
is a recognized side-effect of general and regional anesthesia, once normal 
thermoregulation is inhibited
3
 but Tc is seldom monitored in clinical practice.
8
 
 
IPH is known to be associated with various adverse physiologic effects.
1,9,10 
Hypothermia alters the normal physiology of most body systems and therefore will also 
be altered pharmacokinetics and pharmacodynamics of drugs during this state.
2,11
 Core 
hypothermia may explain situations as broad as: adverse myocardial outcomes in high-
risk patients, significantly augment of blood transfusion and surgical wound 
infection,
8,11,12,13
 delayed post anesthetic recovery,
12
 postoperative negative nitrogen 
balance,
6 
increased mortality in elderly patients with sepsis,
14
 and, with questionable 
clinical significance, alterations on pulse oximetry monitoring and on various 
electrophysiological indices of nervous system.
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Result of an altered distribution of body heat, rather than an imbalance between 
production and heat loss,
4
 hypothermia appears when warming techniques are 
insufficient to counteract thermal redistribution resulting from the ablation of 
thermoregulatory vasoconstriction associated with anaesthesia.
15 
 
Several risk factors are described in literature for the development of IPH. The age 
(advanced), sex, body mass index (BMI) (low) and body surface area, preoperative 
body temperature, history of diabetic neuropathy, emergency surgery, American Society 
of Anesthesiology (ASA) physical status, surgical procedure in which major body 
cavities or major vessels are exposed, anesthetic technique, warming method, amount 
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and temperature of intravenous replacement, duration of anesthesia or surgery and 
ambient operating room temperature are the risk factors that gather more 
consensus.
1,3,12,16 
Risk factors are not  independent and combinations of risk factors may 
be significant. It may also be important to distinguish between factors that make the 
patient more likely to become hypothermic, and those that place the patient at greater 
risk of prolonged hypothermia and/or at greater risk of complications from hypothermia 
because of their inability to recover from the hypothermic state.
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Although risk factors are identified, it is thought that perhaps these can be optimized in 
order to practice a more effective reduction in the incidence of core hypothermia on 
admission at post-anesthesia care unit (PACU).
1 
 
The aim of this study was to estimate the incidence, predictors and outcome of core 
hypothermia on admission at PACU. 
 
Methods 
The approval for this study was provided by the Ethics Committee of Centro Hospitalar 
São João, Porto, Portugal (Chairperson Prof. Dr. Filipe N. A. S. Almeida) on April 
2011. This observational and prospective study was developed in the PACU of this 
central hospital during the period of 9 to 27 May 2011. Of all the participants (340 
patients: table 1 and 2) was obtained a written informed consent, according to this 
particular model work, before surgery.  
 
Exclusion criteria were defined as: age under 18 years; inability to provide informed 
consent or a score of < 25 in the mini-mental state examination (MMSE); patient 
refusal; foreign nationals; urgent/emergent surgery; cardiac surgery; neurosurgery or 
others procedures need to undertake therapeutic hypothermia and known neuromuscular 
disease.  
 
In addition to informed consent, during the preoperative period, it was performed the 
MMSE.
17 
Were also collected data, to a standardized data collection sheet, of the 
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following clinical variables: age, gender, height, weight, ASA physical status, type of 
surgery, pre-existing medical conditions, preoperative medications and an extensive 
check-list for cardiac risk for Revised Cardiac Risk Index (RCRI) assessment according 
to the instructions from authors.
18
 During the intraoperative period were recorded data 
for: type of anesthesia (general/loco regional/combined); duration of anesthesia and 
surgical time; intravenous administered fluids; type of active warming during the 
surgery; neuromuscular block; time of last dose of relaxant and use of neuromuscular 
block reversal drugs. Postoperatively, vital signs and mean train-of-four (TOF) were 
recorded, as well as, length of PACU stay. 
 
For the study of hypothermia, Tc was evaluated by an infrared tympanic membrane 
thermometer (Thermos Scan® Type 6014 Pro 3000, Welch Allyn, with an accuracy of 
± 0.03ºC in the range of 20ºC-42.2ºC – Welch Allyn Medical Products, NY, USA). This 
instrument was maintained and calibrated in accordance with the manufacturer’s 
guidelines.  
 
Patients were classified as hypothermic (Tc <35ºC) or normothermic (Tc ≥35ºC).  
 
For the statistical analyses, ordinal and continuous data found not to follow a normal 
distribution, based on the Kolmogorov-Smimov test for normality of the underlying 
population, are presented as median and interquartile range. Normally distributed data 
are presented as mean and standard deviation (SD).  
 
To identify predictors of hypothermia univariate analyses were performed using non 
parametric tests and Chi-square to compare groups. A multiple logistic regression 
analysis with an odds ratio (OR) and 95% confidence interval (CI) was performed to 
evaluate independent predictors of hypothermia.  
 
All variables were deemed to be significant if p≤0.05. Data were analyzed using SPSS 
for Windows version 16.0 (SPSS, Chicago, IL). 
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Results 
Of a total of 357 patients, 340 were included in the study (table 1 and 2), 17 patients 
were excluded: 7 patients were admitted in a surgical intensive care unit, 3 patients were 
incapable of providing informed consent or had a MMSE < 25, 3 patients were not 
submitted to surgery, 1 patient was excluded because was submitted to a neurosurgery, 
1 was less than 18 years old, 1 did not speak Portuguese and 1 refused to participate. 
 
The mean (± SD) admission Tc was 35.3ºC ± 0.7ºC (interquartile range, 34.9ºC-
35.7ºC); 32.6ºC was the lowest temperature registered and 37.5ºC the maximum. 
Incidence of core hypothermia on the admission at PACU was 32.4% (110 patients). 
85.9% of patients had less than 36.0ºC.  
Patients with hypothermia (table 3 and 4) had more frequently age ≥65 years (42% 
versus 30%, p=0.025) had lower body mass index (25.9  5.0 versus 27.8  5.9, 
p=0.001), were more frequently submitted to high risk surgery (35% versus 24%, 
p=0.040), had higher scores in RCRI (RCRI >2, 8% versus 3%, p=0.019), had more 
frequently general anesthesia as a unique technic (72% versus 13% for locorregional, 
p=0.016) and more frequently used a forced-air warming technic (42% versus 28%, 
p=0.013). The total amount of intravenous crystalloids administrated were higher 
(median of 1.724 versus 1.236 L., p<0.001) and they had shorter fasting times (14.0 ± 
3.8 versus 15.0 ± 4.0 hours, p=0.025), longer duration of anesthesia (median of 150 
versus 102 min., p<0.001) and of surgery (median of 110 versus 70 min., p<0.001) and 
they presented higher scores for visual analogue scale of pain (VAS >3, median of 2.5 
versus 1.0, p=0.031). Hypothermia was neither a risk factor for hospital mortality nor a 
predictor for longer hospital permanence but was for longer length post-anesthesia care 
unit stay (median 106 versus 90 min., p=0.009). 
In multiple logistic regression analysis (table 5), independent predictors of hypothermia 
were: BMI (OR 0.93, 95% CI, 0.89-0.98, p=0.006), RCRI >2 (OR 3.40, 95% CI, 1.13-
10.2, p=0.029), duration of anesthesia (OR 1.52, 95% CI, 1.27-1.83, p<0.001), and VAS 
pain at PACU admission (OR 1.74, 95% CI, 1.05-2.87, p=0.031). 
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The assessment of vital signs (table 6) showed that were no statistically significant 
differences between patients with hypothermia versus normothermia, except with regard 
to pain evaluation at PACU admission. 
 
During our study, 2 participants died. One of them was hypothermic and the other not, 
and no statistical inferences were made.  
 
Discussion 
The incidence of hypothermia at PACU admission was higher than other studies that 
have considered the same cut-off of 35ºC to define hypothermia.
1,12,19 
In a previous 
published study, performed in the same Department, authors’ found a higher incidence, 
but the studied cohort was composed of critical care surgical patients.
12
 
 
The use of infrared tympanic thermometers to measure patient’s temperatures has been 
referred as a potential limitation for temperature evaluation.
1,12,20 
Nierman found that 
comparing the ‘gold standard’ of a thermistor in a pulmonary artery catheter21 to 
infrared tympanic, the tympanic thermometer present a bias (mean difference) of 0.1–
0.4% less than thermistors, situation that could overestimate hypothermia, when the 
measurement is made by tympanic thermometers.
19 
Therefore, considering the greatest 
reported bias, the real incidence of hypothermia in our study could have been slightly 
lower. About this matter, Sessler stated that when infrared signals are obtained exactly 
from the tympanic membrane, the result is real Tc. The limitation that Sessler 
recognizes to this type of evaluation is that there are infrared systems that, for its size, 
do not allows to reach the tympanic membrane and therefore are used only in aural 
canal performing an insufficiently accurate measure for clinical use.
7
 
 
The strongest independent predictor of hypothermia we found was the RCRI >2. There 
is also a significant, but not independent, positive risk relation between hypothermia 
and the utilization of general anesthesia performed as a single technic, compared to 
locorregional anesthesia; general anesthesia technic is usually referred as a risk factor 
for hypothermia.
12
 In fact, the process of heat redistribution during neuraxial anesthesia 
is different, once it is generally restricted to the lower body. Thus, redistribution 
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decreases Tc about half as much when compared with other anesthesia technic but, 
constriction in legs is blocked peripherally, which means that for patients with long 
neuraxial anesthetic times, there is the potential of serious hypothermia.
3  
And some 
evidence shows that passive thermal insulation of the patients did not minimize 
intraoperative hypothermia during spinal anesthesia.
22 
Neuraxial anesthesia is often 
supplemented with sedatives and analgesics that impair thermoregulatory control even 
further.
23 
 
Similarly to other studies, this study identified as risk factors for hypothermia at PACU 
admission, among others: advanced age,
1,12
 the use of large amounts of intravenous 
fluids, duration of surgery or anesthesia
12
and high risk surgery.
24
 
 
National Institute for Health and Clinical Excellence (NICE), assume that age is not an 
important risk factor for the incidence of hypothermia, either intra or postoperatively, 
although the data on Tc suggests that older people (over 60 years) have lower 
temperatures after 3 hours of surgery and at PACU arrival; besides, some consequences 
of hypothermia are more severe for older people, especially morbid cardiac events.
3
 
 
As regards to intravenous fluids, if warmed (38-40ºC) to a temperature higher than 
operating room’s there is a proved beneficial to patients in terms of  hemodynamic 
stability, and for the development of a higher Tc.
22
 
 
According to Putzu et al,
8 
independently of anesthesia technic surgical patients always 
develop perioperative hypothermia when surgical procedure lasts more than 30 minutes. 
This is in agreement with our study, and others, which found that duration of anesthesia 
or surgery, are risk factors for hypothermia.
1 
 
For the result found for VAS >3, we can speculate whether it is pain that increases the 
incidence of hypothermia or if hypothermia leads to more pain postoperatively. 
Although, Persson et al in their study, conclude that there were no postoperative 
differences in analgesic requirements or pain intensity between normothermic and 
hypothermic patients.
25 
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In our study, from the statistical point of view, the use of warming methods was not a 
protective factor as previously reported.
1,26,27
 It should be noted, that these studies 
referred other warming methods than those used in our study, specifically to heat the 
entire operating theater. Besides, an OR of 1.84 for the use of warming methods could 
be explained by the fact that these warming methods are used more frequently in 
surgical procedures and in patients with an increased risk ad initio. It is noteworthy that 
preoperative skin surface warming, for an average of 72 min, reduced the impact of 
core-periphery temperature redistribution without significantly elevating preoperative 
Tc and decreases the incidence of IPH.
15 
 
Hart et al
22
, cites Sessler stating that forced air warmers are one of the most effective 
means of warming a patient. These warmers work better intraoperatively when the 
patient’s periphery is vasodilated. Without pre-warming, however, intraoperative 
warming techniques, including those employing forced air warming, still fail to 
eliminate the initial fall in temperature.
28
Although, extra warming with forced air 
(compared to routine thermal care) was effective in reduce incidence of surgical wound 
infections and postoperative cardiac complications. There are significant benefits 
associated with forced-air warming.
22 
 
In our study, we did not found a relationship between ASA physical status and core 
hypothermia. Although, others have claimed that ASA grade greater than ASA I is a 
risk factor for perioperative hypothermia, and that the risk increases with ASA grade.
3
 
 
Of the variables considered in this study, the BMI was a protective variable for core 
hypothermia, similarly to what has already been indicated by other studies.
1 
NICE 
admitted that increased body weight may have a small protective effect on the incidence 
of perioperative hypothermia in PACU, but the evidence for body weight and body fat 
in thermic regulation is inconsistent.
3
 
 
In conclusion, although the adverse effects of hypothermia in surgical patients are well 
known, incidence remains higher than desirable. Awareness of this fact and of the 
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predictors of perioperative hypothermia is critical to its prevention and to optimize 
clinical care provided to patients.  
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Table 1. Preoperative characteristics of patients (n= 340) 
  
 
Variable 
Mean  SD, median and P25-P75 or 
number (%) 
Age Median 57 (44-6), mean 55.6  16.0  
< 65 / 65 years 226 (67) / 114 (34) 
Male / Female 146 (43) / 194 (57) 
Body mass index (Kg/m²) 27.2  5.7/ 26 (23-30) 
ASA physical status  
I/II 277 (82) 
III/IV/V 63 (19) 
High risk surgery 93 (27) 
Heart disease  
Ischemic 21 (6) 
Congestive 20 (6) 
Cerebrovascular disease 9 (3) 
Insulintherapy for diabetes 49 (14) 
Preoperative serum creatinine >2 mg/dl 17 (5) 
RCRI  
≤2 326 (96) 
>2 15 (4) 
COPD 19 (6) 
Hypertension 141 (42) 
Hyperlipidemia 92 (27) 
 
SD, Standart deviation; P25 and P75, 25th and 75th percentiles; ASA, American Society of Anesthesiologists; RCRI, 
Revised Cardiac Risk Index; COPD, Chronic obstructive pulmonary disease. 
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Table 2. Perioperative characteristics of patients (n=340) 
 
Variable 
Mean  SD, median and P25-P75 or 
number (%) 
Magnitude of surgery  
Minor   35 (10) 
Medium  213 (63) 
Major  34 (10) 
Surgical risk   
Minor 74 (22) 
Medium 232 (68) 
Major 34 (10) 
Type of anesthesia  
General 231 (68) 
Regional  69 (20) 
Combined  30 (9) 
Sedation/analgesia 10 (3) 
Warming methods 116 (34) 
Fluids 24 (7) 
Forced-air warming technic 111 (33) 
Intraoperative fluids  
Intravenous crystalloids (L.)  1,394  1,045 (1,000-1,875) 
Intravenous colloids (L.)  25.0  128 (0-0) 
Packed erythrocytes (Units)  8.8  53.6 (0-0) 
Fresh frozen plasma (Units)  0  0 (0-0) 
Duration of anesthesia (min.) 134  79 / 120 (71-180) 
Duration of surgery (min.) 99  67 / 80 (50-130) 
Temperature on admission 35.3 ± 0.7 /35.3 (34.9-35.7) 
<35ºC 110 (32) 
Length of PACU stay (hours)  116  92/ 95 (65-130)  
Length of Hospital stay (days) 8  13 / 2 (4-7) 
 
SD, Standart deviation; P25 and P75, 25th and 75th percentiles; PACU, Postoperative Anesthesia Care Unit. 
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Table 3. Analysis of categorical and continuous preoperative variables of core hypothermia  
Variable > 35ºC ≤ 35ºC p-value 
Age 54.6  15.6 / 56  
(44-66) 
57.7  16.7 / 60  
(47-71) 
0.053 
< 65 / 65 162 (70) / 68 (30) 64 (58) /46 (42) 0.025 
Male / Female 91 (40) / 139 (60) 55 (50) / 55 (50) 0.069 
Body Mass Index (Kg/m
2
) 27.8  5.9 / 27  
(24-31) 
25.9  5.0 / 27  
(22-28) 
0.001 
ASA physical status   0.854 
I/II 188 (82) 89 (81)  
III/IV/V 42 (18) 21 (19)  
High risk surgery 55 (24) 38 (35) 0.040 
Heart disease    
Ischemic 11 (5) 10 (9) 0.123 
Congestive 11 (5) 9 (8) 0.213 
Cerebrovascular disease 7 (3) 2 (2) 0.510 
Insulintherapy for diabetes 36 (16) 13 (12) 0.346 
Preop. serum creatinine>2 mg/dl 9 (4) 8 (7) 0.184 
RCRI   0.019 
≤2 224 (97) 102 (93)  
>2 6 (3) 9 (8)  
Hypertension 96 (42) 45 (41) 0.884 
Hyperlipidemia 64 (28) 28 (26) 0.646 
COPD 12 (5) 7 (6) 0.667 
   
SD, Standart deviation; P25 and P75, 25th and 75th percentiles; ASA, American Society of Anesthesiologists; RCRI, 
Revised Cardiac Risk Index; COPD, Chronic obstructive pulmonary disease. 
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Table 4. Analysis of categorical and continuous perioperative variables of core hypothermia 
Variable > 35ºC ≤ 35ºC p-value 
Magnitude of surgery   0.162 
Minor 24 (10) 11 (10)  
Medium 151 (66) 62 (56)  
Major 55 (24) 37 (34)  
Surgical risk   0.106 
Minor 57 (25) 17 (16)  
Medium 153 (66) 79 (72)  
Major 20 (9) 14 (13)  
Type of anesthesia   0.016 
General 152 (66) 79 (72)  
Locoregional 55 (24) 14 (13)  
Combined 17 (7) 15 (14)  
Sedation/analgesia 8 (4) 2 (2)  
Warming methods 62 (28) 48 (41) 0.010 
Fluids 17 (7) 7 (6) 0.729 
Forced-air warming technic 65 (28) 46 (42) 0.013 
Intraop fluids    
Intravenous crystalloids (L.) 1.236  0.910  
(1.000-1.125) 
1.724  1.246  
(1.000-2.380) 
< 0.001 
Intravenous colloids (L.) 17.4  103.0 (0-0) 40.9  167.7 (0-0) 0.147 
Packed erythrocytes (Units) 6.5  39.9 (0-0) 13.6  74.5 (0-0) 0.584 
Fresh frozen plasma (Units) 0  0 (0-0) 0  0 (0-0) 1 
Fasting (hours) 15.0  4.0 14.0  3.8 0.025 
Duration of anesthesia (min.) 120  75 / 102  
(60-150) 
163  81 / 150 (99-210) <0.001 
Duration of surgery (min.) 88  63 / 70 (40-120) 120  69 / 110 (60-162) <0.001 
Tc admission <35ºC 35.6 ± 0.4 / 35.6  
(35.3-35.9) 
34.6 ± 0.5 / 34.6  
(34.4-34.9) 
 
Length of PACU stay (min.) 106  92 / 90 (65-125) 137  121 / 106 (75-147) 0.009 
Length of Hospital stay (days) 7.2  12.0 / 4 (2-7) 8.3  14.1 / 5 (2-8) 0.167 
VAS ˃3 2.22  2.74 / 1 (0.0-4.0) 2.84  2.90 / 2.5 (0.0-5.0) 0.031 
 
SD, Standart deviation; P25 and P75, 25th and 75th percentiles; PACU, Postoperative Anesthesia Care Unit; VAS, 
Visual Analogue Scale (of pain). 
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Table 5. Predictors of core hypothermia by multiple logistic regression 
 
Variable 
 
Odds ratio (95% CI) 
 
p-value 
 
Odds ratio (95%CI) 
 
p-value 
Age 65 1.71 (1.07-2.75) 0.026   
Body Mass Index (Kg/m2) 0.94 (0.89-0.98) 0.005 0.93 (0.89-0.98) 0.006 
High risk surgery 1.68 (1.02-2.76) 0.041   
RCRI     
≤2 1  1  
>2 3.33 (1.15-9.60) 0.026 3.40 (1.13-10.2) 0.029 
General anesthesia  2.16 (1.14-4.08) 0.018   
Warming methods 1.84 (1.15-2.96) 0.011   
Intravenous crystalloids (L.) 1.58 (1.24- 2.02) <0.001   
Duration of anesthesia (hours) 1.50 (1.25-1.79) <0.001 1.52 (1.27-1.83) <0.001 
Duration of surgery (hours) 1.52 (1.24-1.87) <0.001   
VAS>3 1.86 (1.16- 3.00) 0.010 1.74 (1.05-2.87)  0.031 
 
RCRI, Revised Cardiac Risk Index; VAS, Visual Analogue Scale (of pain). 
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Table 6: Vital signs in normo and hypothermic patients 
 
Variable Total Normothermic Hipothermic p-value 
SBP (mmHg) 129  25  131  24 127  27 0.161 
DBP (mmHg) 69  14 70  13  69  15 0.512 
HR (bpm) 74 16 75  16  74 16 0.630 
O2Sat (%) 96  3,4 96  3 97  4 0.162 
     
VAS>3 110 64 (28) 46 (42) 0.010 
 
SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; O2Sat, oxygen saturation; 
VAS, Visual Analogue Scale (of pain). 
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